Detection of minor drug-resistant populations by parallel allele-specific sequencing
- PMID: 17206150
- DOI: 10.1038/nmeth995
Detection of minor drug-resistant populations by parallel allele-specific sequencing
Erratum in
- Nat Methods. 2007 Feb;4(2):187
Abstract
We developed a highly sensitive parallel allele-specific sequencing (PASS) assay to simultaneously analyze a large number of viral genomes and detect minor drug-resistant populations at approximately 0.1-0.01% levels. Using this assay on samples from individuals infected with human immunodeficiency viruses (HIV), we successfully detected and quantified minor populations of drug-resistant viruses and performed linkage analysis of multiple-drug resistance mutations. This assay may serve as a useful tool to study drug resistance in HIV and other infectious agents.
Similar articles
-
Minority quasispecies of drug-resistant HIV-1 that lead to early therapy failure in treatment-naive and -adherent patients.Clin Infect Dis. 2009 Jan 15;48(2):239-47. doi: 10.1086/595703. Clin Infect Dis. 2009. PMID: 19086910
-
In vivo emergence of drug-resistant mutations at less than 50 HIV-1 RNA copies/mL that are maintained at viral rebound in longitudinal plasma samples from human immunodeficiency virus type-1-infected patients on highly active antiretroviral therapy.J Hum Virol. 2001 Nov-Dec;4(6):317-28. J Hum Virol. 2001. PMID: 12082398
-
Longitudinal Detection and Persistence of Minority Drug-Resistant Populations and Their Effect on Salvage Therapy.PLoS One. 2015 Sep 11;10(9):e0135941. doi: 10.1371/journal.pone.0135941. eCollection 2015. PLoS One. 2015. PMID: 26360259 Free PMC article.
-
Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Verh K Acad Geneeskd Belg. 2001. PMID: 11813503 Review.
-
[Drug resistance in antiretroviral therapy of HIV infection].Med Klin (Munich). 2003 Dec 15;98(12):692-9. doi: 10.1007/s00063-003-1315-4. Med Klin (Munich). 2003. PMID: 14685670 Review. German.
Cited by
-
Persistence of Human Immunodeficiency Virus-1 Drug Resistance Mutations in Proviral Deoxyribonucleic Acid After Virologic Failure of Efavirenz-Containing Antiretroviral Regimens.Open Forum Infect Dis. 2019 Jan 16;6(3):ofz034. doi: 10.1093/ofid/ofz034. eCollection 2019 Mar. Open Forum Infect Dis. 2019. PMID: 30863788 Free PMC article.
-
Simultaneous detection of major drug resistance mutations in the protease and reverse transcriptase genes for HIV-1 subtype C by use of a multiplex allele-specific assay.J Clin Microbiol. 2013 Nov;51(11):3666-74. doi: 10.1128/JCM.01669-13. Epub 2013 Aug 28. J Clin Microbiol. 2013. PMID: 23985909 Free PMC article.
-
External Quality Assessment for Next-Generation Sequencing-Based HIV Drug Resistance Testing: Unique Requirements and Challenges.Viruses. 2020 May 16;12(5):550. doi: 10.3390/v12050550. Viruses. 2020. PMID: 32429382 Free PMC article.
-
Simple PCR assays improve the sensitivity of HIV-1 subtype B drug resistance testing and allow linking of resistance mutations.PLoS One. 2007 Jul 25;2(7):e638. doi: 10.1371/journal.pone.0000638. PLoS One. 2007. PMID: 17653265 Free PMC article.
-
Prevalence and impact of minority variant drug resistance mutations in primary HIV-1 infection.PLoS One. 2011;6(12):e28952. doi: 10.1371/journal.pone.0028952. Epub 2011 Dec 16. PLoS One. 2011. PMID: 22194957 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical